Welcome to Insider Cannabis, our weekly newsletter where we’re bringing you an inside look at the deals, trends, and personalities driving the multibillion-dollar global cannabis boom.
Sign up here to get it in your inbox every week.
Happy Friday readers,
With the House vote on the MORE Act delayed, all eyes in the cannabis world were on Aurora’s dismal earnings.
The first earnings call under new CEO Miguel Martin was a tough one — the company lost close to $1.9 billion (CAD) in the quarter — and analysts say the company has a long way to go to turn things around. You can read my full story on the earnings here.
Elsewhere in public markets, psychedelic medicine company Compass Pathways had a stellar week of trading. Expect to see lots of psychedelic companies, of varying quality, try and pile into the market, piggybacking off of Compass Pathways’ success.